Search results
HIV is a virus that remains a major health concern and results in an infection that has no cure even after over 30 years since its discovery. As such, HIV vaccine discovery continues to be an area of intensive research. In this review, we summarize the most recent HIV vaccine efficacy trials, clinical trials initiated within the last 3 years ...
20 gru 2023 · Multiple groups developed safe and effective SARS-CoV-2 vaccines in an unprecedented timeframe of 1 year, 6–8 leading to the question: why has development of an HIV-1 vaccine taken more than 40 years? Development of SARS-CoV-2 vaccines benefited from previous research in related viruses causing severe acute respiratory syndrome and Middle ...
27 gru 2023 · Women and gender diverse people face unique challenges and have been under-represented in HIV research. The National Institutes of Health (NIH) is tasked to apply fundamental knowledge about the nature and behaviour of living systems to enhance health, lengthen life, and reduce disability.
HIV is a virus that remains a major health concern and results in an infection that has no cure even after over 30 years since its discovery. As such, HIV vaccine discovery continues to be an area of intensive research. In this review, we summarize the most recent HIV vaccine efficacy trials, clinic …
2 kwi 2024 · Universal vaccination: To reduce community transmission and protect individuals with HIV, this committee agrees with the CDC recommendations for universal vaccination against COVID-19 for adults (≥18 years old) with HIV, regardless of prior history of COVID-19 infection.
28 paź 2013 · So far, a safe and effective HIV vaccine remains elusive. A large number of scientists began working on a vaccine against HIV, and clinical trials started within 4 years of the isolation of...
24 lip 2024 · Cisgender women account for approximately half the 1.3 million new human immunodeficiency virus (HIV) infections that occur worldwide each year. 1 The first HIV preexposure prophylaxis...
